Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

POLYMYXIN B SULFATE

POLYMYXIN B SULFATE

Standard Dose
EQ 500,000 UNITS BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview POLYMYXIN B SULFATE is listed in Drugs@FDA under application 207322 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient POLYMYXIN B SULFATE Form and strength INJECTABLE;INJECTION - EQ 500,000 UNITS BASE/VIAL Sponsor GLAND Submission history Latest submission status date: 2025-07-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview POLYMYXIN B SULFATE is listed in Drugs@FDA under application 207322 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient POLYMYXIN B SULFATE Form and strength INJECTABLE;INJECTION - EQ 500,000 UNITS BASE/VIAL Sponsor GLAND Submission history Latest submission status date: 2025-07-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.